Log in

NASDAQ:JYNTJoint Stock Price, Forecast & News

$15.11
+0.18 (+1.21 %)
(As of 05/29/2020 04:00 PM ET)
Add
Compare
Today's Range
$14.40
Now: $15.11
$15.28
50-Day Range
$10.50
MA: $12.21
$15.82
52-Week Range
$7.67
Now: $15.11
$21.80
Volume58,813 shs
Average Volume119,411 shs
Market Capitalization$210.63 million
P/E Ratio68.68
Dividend YieldN/A
Beta1.09
The Joint Corp. develops, owns, operates, supports, and manages chiropractic clinics. The company operates through two segments, Corporate Clinics and Franchise Operations. It operates through direct ownership, management arrangements, franchising, and the sale of regional developer rights. As of March 07, 2019, the company operated 450 clinics in the United States. The company was founded in 2010 and is headquartered in Scottsdale, Arizona.
Read More
Joint logo

Beat the Market (BTM) Rank

Analyst Opinion: 3.5Community Rank: 2.5Dividend Strength: 0.0Insider Behavior: 4.0Valuation: 1.9 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

2.38 out of 5 stars


Industry, Sector and Symbol

Industry Patent owners & lessors
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:JYNT
CUSIPN/A
Phone480-245-5960

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$48.45 million
Cash Flow$0.38 per share
Book Value$0.50 per share

Profitability

Net Income$3.32 million

Miscellaneous

Employees138
Market Cap$210.63 million
Next Earnings Date8/13/2020 (Estimated)
OptionableNot Optionable

Receive JYNT News and Ratings via Email

Sign-up to receive the latest news and ratings for JYNT and its competitors with MarketBeat's FREE daily newsletter.

Joint (NASDAQ:JYNT) Frequently Asked Questions

How has Joint's stock been impacted by COVID-19 (Coronavirus)?

Joint's stock was trading at $13.61 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, JYNT shares have increased by 11.0% and is now trading at $15.11. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Joint?

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Joint in the last year. There are currently 5 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Joint.

When is Joint's next earnings date?

Joint is scheduled to release its next quarterly earnings announcement on Thursday, August 13th 2020. View our earnings forecast for Joint.

How were Joint's earnings last quarter?

Joint Corp (NASDAQ:JYNT) posted its quarterly earnings data on Thursday, May, 7th. The company reported $0.06 earnings per share for the quarter, missing analysts' consensus estimates of $0.07 by $0.01. The business had revenue of $13.64 million for the quarter, compared to analysts' expectations of $13.03 million. Joint had a net margin of 6.20% and a return on equity of 66.44%. View Joint's earnings history.

What guidance has Joint issued on next quarter's earnings?

Joint issued an update on its FY 2020 After-Hours earnings guidance on Thursday, March, 5th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $61-63 million, compared to the consensus revenue estimate of $61.6 million.

What price target have analysts set for JYNT?

5 analysts have issued 12 month price targets for Joint's shares. Their forecasts range from $20.00 to $32.00. On average, they expect Joint's share price to reach $25.40 in the next twelve months. This suggests a possible upside of 68.1% from the stock's current price. View analysts' price targets for Joint.

What are Wall Street analysts saying about Joint stock?

Here are some recent quotes from research analysts about Joint stock:
  • 1. According to Zacks Investment Research, "The Joint Corp. is a healthcare franchisor of chiropractic clinics. The Company's plans include: Single Visit, Premium Wellness Plan and Wellness Plan. It also provides a family wellness plan. The Company also provides removal of subluxations. It operates its clinics across: Albany, New York; Austin, Texas; Brentwood, California; Fort Mill, South Carolina; Lubbock, Texas; Lynnwood, Washington; Middletown, New Jersey; San Antonio, Texas; San Diego, California and Spartanburg, South Carolina, among others. The Joint Corp. is headquartered in Scottsdale, Arizona. " (4/2/2020)
  • 2. Maxim Group analysts commented, "Market close, JYNT reported relatively inline 2Q19 revenue results and reiterated 2019 guidance. The company opened 14 franchise clinics in 2Q19 versus our estimate of 17, for a total of 417 franchises. JYNT also opened one greenfield clinic bringing that total up to 51. We are increasing our 2020 revenue estimate as we expect the company to continue to open franchise and greenfield clinics while expanding its national footprint. Also, we are introducing our 2020 quarterly estimates." (8/9/2019)

Has Joint been receiving favorable news coverage?

Headlines about JYNT stock have trended extremely negative this week, according to InfoTrie. The research firm ranks the sentiment of press coverage by analyzing more than six thousand blog and news sources in real-time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores closest to five being the most favorable. Joint earned a daily sentiment score of -4.3 on InfoTrie's scale. They also assigned media stories about the company a news buzz of 1.0 out of 10, meaning that recent press coverage is extremely unlikely to have an effect on the company's share price in the near term. View the latest news aboutJoint.

Are investors shorting Joint?

Joint saw a decrease in short interest in the month of May. As of May 15th, there was short interest totaling 1,940,000 shares, a decrease of 6.7% from the April 30th total of 2,080,000 shares. Based on an average trading volume of 157,900 shares, the short-interest ratio is currently 12.3 days. Approximately 14.8% of the company's stock are sold short. View Joint's Current Options Chain.

Who are some of Joint's key competitors?

What other stocks do shareholders of Joint own?

Who are Joint's key executives?

Joint's management team includes the following people:
  • Mr. Peter D. Holt, CEO, Pres & Director (Age 60)
  • Jake Singleton, Chief Financial Officer (Age 37)
  • Mr. Jorge Armenteros, VP of Operations
  • Dr. James Edwards, Chief Chiropractic & Compliance Officer
  • Mr. Craig P. Colmar, Sec. (Age 66)

When did Joint IPO?

(JYNT) raised $20 million in an IPO on Tuesday, November 11th 2014. The company issued 3,000,000 shares at a price of $6.50 per share. Roth Capital Partners and Feltl and Company served as the underwriters for the IPO and Sanders Morris Harris was co-manager.

What is Joint's stock symbol?

Joint trades on the NASDAQ under the ticker symbol "JYNT."

Who are Joint's major shareholders?

Joint's stock is owned by a number of retail and institutional investors. Top institutional investors include Bandera Partners LLC (12.07%), BlackRock Inc. (6.37%), Skylands Capital LLC (5.31%), Acadian Asset Management LLC (1.85%), State Street Corp (1.75%) and Geode Capital Management LLC (1.24%). Company insiders that own Joint stock include Bandera Partners Llc, Glenn J Krevlin, Jake Singleton, James H Amos Jr, John P Meloun, Peter D Holt and Ronald V Davella. View institutional ownership trends for Joint.

Which major investors are selling Joint stock?

JYNT stock was sold by a variety of institutional investors in the last quarter, including Morgan Stanley, Squarepoint Ops LLC, GSA Capital Partners LLP, Strs Ohio, Nuveen Asset Management LLC, Engineers Gate Manager LP, Russell Investments Group Ltd., and THB Asset Management. View insider buying and selling activity for Joint.

Which major investors are buying Joint stock?

JYNT stock was bought by a variety of institutional investors in the last quarter, including Bandera Partners LLC, Grandeur Peak Global Advisors LLC, Wasatch Advisors Inc., Skylands Capital LLC, Old Well Partners LLC, Scholtz & Company LLC, Two Sigma Investments LP, and Globeflex Capital L P. Company insiders that have bought Joint stock in the last two years include Bandera Partners Llc, Jake Singleton, James H Amos Jr, and Peter D Holt. View insider buying and selling activity for Joint.

How do I buy shares of Joint?

Shares of JYNT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Joint's stock price today?

One share of JYNT stock can currently be purchased for approximately $15.11.

How big of a company is Joint?

Joint has a market capitalization of $210.63 million and generates $48.45 million in revenue each year. The company earns $3.32 million in net income (profit) each year or $0.23 on an earnings per share basis. Joint employs 138 workers across the globe.

What is Joint's official website?

The official website for Joint is www.thejoint.com.

How can I contact Joint?

Joint's mailing address is 16767 N PERIMETER DRIVE SUITE 240, SCOTTSDALE AZ, 85260. The company can be reached via phone at 480-245-5960 or via email at [email protected]

This page was last updated on 5/31/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.